Plavix Patent Trial Postponed
This article was originally published in The Pink Sheet Daily
Executive Summary
The patent infringement case regarding Bristol-Myers Squibb/Sanofi-Aventis' blood thinning product Plavix (clopidogrel) has been postponed by approximately two months